Clincosm LogoSign in Get a demo

urothelial cancer

Showing 1 - 25 of 48
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adults in South Korea With Cancer Who Receive PADCEV Injection

Recruiting
  • Urothelial Cancer
  • Enfortumab Vedotin
  • Seoul, Korea, Republic of
    KR82004
Aug 22, 2023

Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

Recruiting
  • Endometrial Cancer
  • +8 more
  • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
  • Orlando, Florida
  • +21 more
Feb 2, 2023

Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

OBSERVATIONAL STUDY OF AVELUMAB AS FIRST-LINE MAINTENANCE

Recruiting
  • Urothelial Cancer
  • Bristol, United Kingdom
  • +9 more
Jan 23, 2023

Urothelial Cancer and Rare Genitourinary Tract Malignancies

Recruiting
  • Urothelial Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)

    Recruiting
    • Advanced Solid Tumors
    • +5 more
    • Scottsdale, Arizona
    • +7 more
    Jan 23, 2023

    Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy

    Recruiting
    • Urothelial Cancer
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)

    Recruiting
    • Urothelial Cancer
    • Beijing, China
      Beijing Cancer Hospital
    Jan 18, 2023

    Urothelial Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Gemcitabine)

    Recruiting
    • Urothelial Cancer
    • Nivolumab
    • +4 more
    • Birmingham, Alabama
    • +196 more
    Jan 17, 2023

    Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

    Recruiting
    • Advanced Malignancies
    • +4 more
    • Fayetteville, Arkansas
    • +61 more
    Jan 10, 2023

    Advanced Solid Tumor, Metastatic Solid Tumor, Urothelial Carcinoma Trial in United States (Lurbinectedin)

    Recruiting
    • Advanced Solid Tumor
    • +4 more
    • Stanford, California
    • +15 more
    Dec 21, 2022

    Carcinoma, Transitional Cell, Urinary Bladder Tumors, Urologic Tumors Trial in Worldwide (enfortumab vedotin (EV),

    Active, not recruiting
    • Carcinoma, Transitional Cell
    • +6 more
    • enfortumab vedotin (EV)
    • +4 more
    • Anchorage, Alaska
    • +105 more
    Dec 19, 2022

    Non Small Cell Lung Cancer, Urothelial Cancer, Ovarian Cancer Trial in United States (XB002, Nivolumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • +9 more
    • Saint Louis, Missouri
    • +4 more
    Dec 12, 2022

    Colorectal Cancer, NSCLC, Triple Negative Breast Cancer Trial in Spain, United Kingdom, United States (GEN1029

    Terminated
    Has Results
    • Colorectal Cancer
    • +6 more
    • GEN1029 (HexaBody®-DR5/DR5)
    • New Haven, Connecticut
    • +5 more
    Nov 11, 2022

    Urothelial Cancer Trial in Spain (Nivolumab, Ipilimumab)

    Recruiting
    • Urothelial Cancer
    • Huelva, Andalucia, Spain
    • +11 more
    Dec 1, 2022

    Urothelial Cancer Trial in Worldwide (MEDI4736 (Durvalumab), Tremelimumab, Cisplatin)

    Active, not recruiting
    Has Results
    • Urothelial Cancer
    • MEDI4736 (Durvalumab)
    • +4 more
    • Los Angeles, California
    • +221 more
    Nov 2, 2022

    Urothelial Cancer Trial in Worldwide (Avelumab, Best Supportive Care, Following the planned interim analysis for this study:

    Active, not recruiting
    Has Results
    • Urothelial Cancer
    • Avelumab
    • +2 more
    • Aurora, Colorado
    • +370 more
    Oct 24, 2022

    Non Small Cell Lung Cancer, Urothelial Cancer, Renal Cell Carcinoma Trial in Worldwide (INCB086550)

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • +4 more
    • Burgas, Bulgaria
    • +19 more
    Oct 20, 2022

    NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab 800 mg in combination with pemetrexed / carboplatin, Avelumab 800 mg in

    Active, not recruiting
    Has Results
    • Non-small Cell Lung Cancer
    • Urothelial Cancer
    • Avelumab 800 mg in combination with pemetrexed / carboplatin
    • +3 more
    • Tucson, Arizona
    • +45 more
    Oct 13, 2022

    Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in

    Recruiting
    • Urothelial Cancer
    • +3 more
    • Sacituzumab Govitecan (SG)
    • Enfortumab vedotin-ejfv (EV)
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Sep 28, 2022

    Care of Urothelial Cancer Patient and Prospective Procurement of

    Recruiting
    • Bladder Cancer
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Urothelial Cancer Trial (pembrolizumab)

      Completed
      Has Results
      • Urothelial Cancer
      • pembrolizumab
      • (no location specified)
      Aug 18, 2022

      NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab (MSB0010718C), Axitinib (AG-013736))

      Active, not recruiting
      • Non-Small Cell Lung Cancer
      • Urothelial Cancer
      • Avelumab (MSB0010718C)
      • Axitinib (AG-013736)
      • Glendale, Arizona
      • +36 more
      Aug 16, 2022

      Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer Trial in Worldwide (BT5528,

      Recruiting
      • Advanced Solid Tumor Historically Known for High EphA2 Expression
      • +6 more
      • Encinitas, California
      • +27 more
      Aug 17, 2022

      Urothelial Cancer Trial in Worldwide (Erdafitinib, Vinflunine, Docetaxel)

      Recruiting
      • Urothelial Cancer
      • Anchorage, Alaska
      • +414 more
      Jul 14, 2022